Navigation Links
Now AIDS treatment comes dirt-cheap

The war of the pharmaceutical giants has just begun. After waging wars over many drug formulations the pharma majors are now locking horns over AIDS treatment. The ball was set in motion by the dramatic announcement of Indian firm Cipla that a three-drug combination for AIDS treatment would cost less than a U.S. dollar a day. Not to be left far behind rival firm Ranbaxy announced plans of its own production of anti retroviral drugs for AIDS treatment.

This development brings to a head a series of developments in a year that has seen people all over the world ganging up against rising prices of essential life saving medicines. However critics say even now many in the poorer countries will be unable to afford the new drug cocktail as offered by Cipla.

Another argument is that counseling and close monitoring of medication is equally important, at least in the developing world, where treatment for many AIDS patients is still only a dream.

But for the hapless HIV positive victims this news will surely bring some cheer that there is still some chance left. There still is some light at the end of the tunnel.


'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Breast cancer treatment to be determined by gene test
5. Hemopurifier may revolutionise AIDS treatment
6. New drug helps boost cancer treatment
7. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
8. Experimental treatment for Ebola Virus Shows promising results in mice
9. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
10. New dimension in the treatment of female sexual dysfunction
11. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: